World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma presenterar valberedning
Read more >> -
Xbrane Biopharma presents nomination committee
Read more >> -
Xbrane Biopharma publicerar kvartalsrapport för juli - september 2018
Read more >> -
Xbrane Biopharma releases interim report for the third quarter of 2018
Read more >> -
Xbrane Biopharma tillkännager resultat från in-vivo studie som påvisar ekvivalent tolerabilitet och farmakokinetisk profil för Xlucane jämfört med Lucentis®
Read more >>
X
